PG&E Corp

PCG
Country: United StatesPrice: $13.25Market Cap: $29.2B

Investment snapshot

29%positive consensus
Scored 1d ago

Positive

5

BUY / PASS

Neutral / negative

4 / 7

NEUTRAL / FAIL

Median fair value

$15.56

+17.5% vs price

Models with upside

5 / 17

Positive margin of safety

Strongest signal

Models split on PCG at $13.25 — fair values range $11.55–$19.83

Key risk

All 12 investors flag PCG's debt & leverage

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictPASSFAILFAILFAIL · Rank #1440 (Top 46.5%)PASSPASSFAILNEUTRALFAILFAILPASSNEUTRALPASSNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of Safety+33.2%N/A+6.4%+6.9%N/A+21.6%N/AN/A+28.0%N/AN/A-14.7%N/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-10-22

Score computed: 2026-11-14

TTM ended 2026-09-30

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-12

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-12

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-22

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Where It Passes

  • Valuation models83% pass✓ 5✗ 1▾

    Models split on PCG at $13.25 — fair values range $11.55–$19.83

    Graham fair value$19.83
    ✓Graham+33.2% margin vs $13.25
    Lynch fair value$14.15
    ✓Lynch+6.4% margin vs $13.25
    Greenblatt fair value$14.23
    ✓Greenblatt+6.9% margin vs $13.25
    Dreman fair value$16.90
    ✓Dreman+21.6% margin vs $13.25
    Akre fair value$18.40
    ✓Akre+28.0% margin vs $13.25
    Templeton fair value$11.55
    ✗Templeton-14.7% margin vs $13.25
  • Valuation62% pass✓ 20✗ 8▾

    8 of 13 pass — Greenblatt, Ackman, Neff +2 more object

    Price / Book Value per Share0.9x
    ✓Dreman< 1.2x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Price / 3-yr avg EPS11.8x
    ✓Graham<= 15x
    Price-to-Book Ratio0.9x
    ✓Graham<= 1.5x
    P/E x P/B10.50
    ✓Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)0.94
    ✓Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value5.7%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=5.7%, ROC=5.0%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS11.2x
    ✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)3.3x
    ✓Dreman< 8x
    Valuation ReasonablenessP/E=11.2x
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=11.2x, FCF Yield=-10.5%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=11.2x, P/B=0.9x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value21.6% (IV=$16.90 vs Price=$13.25)
    ✓Marks>= 20% below intrinsic value
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Price vs. Trailing Low109% of trailing low ($12.18)
    ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+10.60%; #592/6340 (top 9.3%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+1.1847; #1220/6449 (top 18.9%)
    ✓AsnessTop 30% of eligible cross-section
    Price / Diluted EPS11.2x
    ✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share0.94x
    ✓SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+39.9%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.8832; #1916/5247 (top 36.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-17.05%; #3460/4519 (top 76.6%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-18.91%; #3915/6202 (top 63.1%)
    ✗OshaughnessyTop 10% of eligible cross-section

Where It Falls Short

  • Debt & Leverage0% pass✗ 15▾

    All 12 investors flag PCG's debt & leverage

    LT Debt vs Net Current AssetsLT Debt $61.3B vs NCA $424.0M
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 1.82, IC: 1.6x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity1.82
    ✗Lynch< 0.33
    Cash - Long-term Debt$-60.4B
    ✗LynchPositive preferred
    LT Debt / Total Assets Change40.08% -> 40.52%
    ✗PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.03
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity1.82
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt Levels1.82
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=1.8x, D/EBITDA=N/A (D&A unavailable)
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity1.82
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-1.8171; #3725/4210 (top 88.5%)
    ✗AsnessTop 30% of eligible cross-section
  • Efficiency0% pass✗ 11▾

    All 8 investors flag PCG's efficiency

    Current Ratio1.03
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)3.1%
    ✗Buffett> 10%
    ROIC - WACC-6.9%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)5.0%
    ✗Greenblatt> 25%
    Current Ratio Change YoY1.05 -> 0.97
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.18x -> 0.18x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities1.03
    ✗Dreman> 1.5
    Return on Invested Capital4.2%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=2.7%; FY2024: ROIC=4.1%; FY2025: ROIC=4.1%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC4.1% (RR=100% x ROIC=4.1%)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest 4.1%)
    ✗SleepROIC > 12% in a majority of years
  • Profitability38% pass✓ 17✗ 18▾

    10 of 16 flag PCG's profitability — Graham, Buffett, Lynch +7 more

    Positive EPS (10 years)19/26 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)22/26 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)6.6%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)19.0% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$0.0M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)0.94
    ✓Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR12.0%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    ROE8.9%
    ✗Lynch> 15%
    EBIT / Enterprise Value5.7%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=5.7%, ROC=5.0%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets1.91%
    ✓PiotroskiROA > 0
    ROA Change YoY1.88% -> 1.91% (delta: +0.03%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=6.15%, ROA=1.91%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue10.9%
    ✓Dreman>= 8%
    Net Income / Shareholders' Equity8.9%
    ✗Dreman> 12%
    Margin of SafetyP/E=11.2x, P/B=0.9x
    ✓PabraiP/B < 1.5 or P/E < 15
    Return on Equity8.5% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value21.6% (IV=$16.90 vs Price=$13.25)
    ✓Marks>= 20% below intrinsic value
    Positive Net Income Frequency22/26 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue20.2%
    ✓Ackman>= 15%
    Net Income / Shareholders Equity8.9%
    ✗Ackman>= 15%
    5-Year EPS CAGR12.0% CAGR over 3 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend10.9% (2023) -> 19.0% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 10.9% -> 19.0%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+10.60%; #592/6340 (top 9.3%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+8.94%; #1966/5226 (top 37.6%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0076; #657/5884 (top 11.2%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR12.0% over 3 years
    ✓Neff7%-20% annualized
    Positive Diluted-EPS Years6/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Verdicts38% pass✓ 5✗ 8▾

    Split decision: 7 FAIL · 5 PASS · 4 NEUTRAL

    Overall verdict
    ✓GrahamPASS (4/9)✗BuffettFAIL (0/9)✗LynchFAIL (3/7)✗GreenblattRank #1440✓PiotroskiPASS (F-Score 4)✓DremanPASS (5/11)✗MungerFAIL (1/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (0/6)✗MarksFAIL (3/5)✓AckmanPASS (4/9)•TempletonNEUTRAL (6/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (3/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
  • Cash Flow40% pass✓ 5✗ 7▾

    6 of 10 flag PCG's cash flow — Buffett, Lynch, Marks +3 more

    Free Cash Flow Proxy$0.0M
    ✗BuffettPositive and growing
    FCF Positive and Growing$-5.0B
    ✗LynchPositive and growing
    Operating Cash Flow$8.7B
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=6.15%, ROA=1.91%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)3.3x
    ✓Dreman< 8x
    P/E or FCF YieldP/E=11.2x, FCF Yield=-10.5%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive5/21 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-17.1%
    ✗Ackman>= 4%
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency25/26 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-5.0B
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-17.05%; #3460/4519 (top 76.6%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth50% pass✓ 8✗ 5▾

    4 of 8 pass — Graham, Dreman, Ackman +1 more object

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)0.94
    ✓Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR12.0%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: -8.1% vs Rev: 4.1%
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency22/26 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth2.1%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency5/5 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR12.0% CAGR over 3 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 10.9% -> 19.0%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR6.2%
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR12.0% over 3 years
    ✓Neff7%-20% annualized

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Utilities
SIC Sector: Electric, Gas & Sanitary Services
Size: Large Cap($29.2B)
Revenue: $24.9B+2.1% YoY
Net Income: $2.7B+7.6% YoY

Financial Snapshot

Operating Margin19.0%
Return on Equity8.3%
Debt / Equity1.79
Current Ratio0.97
EPS (Diluted)$1.18+2.6% 1y
Shares Retired−0.2% / −3.0% 2y

Shareholder Return

Fiscal 2025

Issued 0.2% of shares last year, 3.0% issued over two.

Buybacks
—
Dividends
—

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY23
25.0% = 24.4% + 0.5%
FY24
9.5% = 11.3% + −1.6%
FY25
2.6% = 7.6% + −4.6%
Earnings Fewer shares More shares

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, interest expense, operating cash flow, capex.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-02-12
FY 2024
Sources
  • 10-K · 2025-02-13
FY 2023
Sources
  • 10-K · 2025-02-13
FY 2022
Sources
  • 10-K · 2023-02-23
FY 2021
Sources
  • 10-K · 2022-02-10
Market Cap$29.2Bcurrent------$33.9Best.$34.3Best.$35.4Best.$31.1Best.$25.0Best.
Revenue$25.8B↑4%$6.2B↓1%$5.9B$6.9B↑15%$24.9B↑2%$24.4B$24.4B↑13%$21.7B↑5%$20.6B
Operating Income$5.2B↑15%$1.2B↑3%$1.3B↑15%$1.5B↑20%$4.7B↑7%$4.5B↑67%$2.7B↑45%$1.8B↓2%$1.9B
Net Income$3.1B↑14%$776.0M↓9%$761.0M↑39%$885.0M↑40%$2.7B↑8%$2.5B↑11%$2.3B↑24%$1.8B↑2161%-$88.0M
EPS (Diluted)--$0.34↓8%$0.33↑38%$0.39↑39%$1.18↑3%$1.15↑10%$1.05↑25%$0.84↑1780%$-0.05
Gross Margin—————————
Operating Margin20.2%↑10%20.2%↑4%21.4%↑15%21.4%↑5%19.0%↑4%18.3%↑67%10.9%↑29%8.5%↓7%9.1%
ROE8.9%↑6%———8.3%8.3%↓8%9.0%↑13%7.9%↑1994%-0.4%
Total Debt$62.8B↑8%$62.8B↑8%$62.8B↑9%$60.8B↑6%$58.2B↑4%$55.7B↑6%$52.4B↑5%$50.0B↑17%$42.7B
Shareholders' Equity$34.6B↑8%$34.6B↑8%$33.9B↑9%$33.3B↑8%$32.5B↑8%$30.1B↑20%$25.0B↑10%$22.8B↑9%$21.0B
Current Ratio1.03↑9%1.03↑9%1.22↑30%1.20↑26%0.97↓8%1.05↑27%0.83↑2%0.81↑28%0.64
Debt / Equity1.821.821.851.83↓2%1.79↓3%1.85↓12%2.09↓5%2.19↑8%2.04
Operating Cash Flow$7.8B↓10%$2.5B↓12%$906.0M↓14%$2.4B↓15%$8.7B↑8%$8.0B↑69%$4.7B↑28%$3.7B↑65%$2.3B
Free Cash Flow-$5.0B↓80%-$794.0M↓893%-$2.1B↓3%-$926.0M↓535%-$3.1B↓32%-$2.3B↑53%-$5.0B↑15%-$5.9B↓8%-$5.4B

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Utilities

PCG vs Peers — Financial Grading

Revenue$24.9BTop 25%
Net Income$2.7BMedian
ROE8.3%Bottom 25%
D/E1.79Bottom 25%
Op. Margin19.0%Bottom 25%
Curr. Ratio0.97Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
SOUTHERN COSO$109.0B$93.59$29.6B$4.3B12.1%2.0024.7%0.652/92/92/70/3F-Score 53/11
AMERICAN ELECTRIC POWER CO INCAEP$70.3B$129.18$21.9B$3.7B11.9%1.5224.3%0.454/93/92/70/3F-Score 53/11
Cheniere Energy, Inc.LNG$63.0B$308.75$20.0B$5.3B67.3%2.8845.6%0.942/94/94/70/3F-Score 83/11
DOMINION ENERGY, INCD$59.5B$67.66$16.5B$3.0B10.3%1.6026.7%0.772/90/91/70/3F-Score 63/11
ATMOS ENERGY CORPATO$29.8B$176.30$4.7B$1.2B8.8%0.6633.2%0.773/93/92/70/3F-Score 63/11
EVERSOURCE ENERGYES$27.0B$71.73$13.5B$1.7B10.5%1.7522.1%0.652/92/92/70/3F-Score 64/11
PPL CorpPPL$26.9B$35.67$9.0B$1.2B7.9%1.2723.5%0.862/90/90/70/3F-Score 52/11
ALLIANT ENERGY CORPLNT$19.0B$73.43$4.4B$810.0M11.0%1.6423.5%0.802/92/92/70/3F-Score 62/11